Kimberly Clark
Q4 2022 Earnings Call
Jan 25, 2023, 10:00 a.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Ladies and gentlemen, thank you for your patience and holding. We now have your presenters in conference. [Operator instructions] It is now my pleasure to introduce today's first presenter, Christina Cheng.
Christina Cheng -- Investor Relations
Thanks, Shelby. Hello, and welcome to our 2022 year-end earnings conference call. Joining us today are Mike Hsu, our chairman and chief executive officer; Nelson Urdaneta, our chief financial officer; and Brian Ezzell, our VP of finance. We issued our press release and published supplemental materials that summarized our results and outlook this morning.
You can find these resources in the event page of our investor relations website. Before we begin today, a few reminders. Statements today will include forward-looking statements. Please refer to the latest Form 10-K or 10-Q for a list of factors that could cause our actual results to differ materially from expectations.
Our remarks will focus on adjusted results, which will exclude certain items described in our Q4 2022 earnings news release. Please consult our press release and public filings for more information about these adjustments and a reconciliation to comparable GAAP financial measures. Mike will provide his perspective of the business, and then we will open the floor for Q&A. With that, let me turn it over to Mike.
Mike Hsu -- Chairman and Chief Executive Officer
OK. Thank you, Christina, and welcome to K-C. Good morning and thank you all for joining us today. Back when we introduced our strategy in 2019, we could not have imagined the unprecedented challenges we are about to face.
Over the past four years, K-Cers did what we do best, provide great care, care that our consumers, our customers, our employees, and our communities needed all around the world. At the peak of the pandemic, people counted on our brands to support the health and hygiene of their families, and I'm proud of what our teams were able to achieve to fulfill our purpose of better care for a better world. Now, as we look back at our results, there are three themes I'd like to emphasize. Theme number one, our strategy to accelerate growth is working.
Since 2019, we've grown our business by about 1.5 billion in sales and delivered 4% average organic sales growth. In that time, we've accelerated our organic growth by improving our product offering and market positions, with meaningful innovation and world-class commercial execution. In 2022, organic sales increased by 7% and over delivering on our goals at the beginning of the year. This was achieved in what turned out to be a uniquely challenging global environment.